Actively Recruiting
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
Led by Medical University of South Carolina · Updated on 2025-10-07
279
Participants Needed
1
Research Sites
248 weeks
Total Duration
On this page
Sponsors
M
Medical University of South Carolina
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this research study is to evaluate a mobile application (app) for depression treatment called "Moodivate" among cancer survivors. Moodivate was developed by our research team to assist with the treatment of depressed mood. Participants will be randomly assigned to either download the mobile app, "Moodivate", or not. Approximately 2/3 of participants enrolled will receive the mobile app and the remaining 1/3 will not. All participants will complete electronic questionnaire measures throughout the study period. Questionnaires will assess symptoms of depression, as well as your experiences using Moodivate and participating in this trial. Participation in this study will take about 12 weeks, beginning today. Participation in this study may help in the treatment of future cancer survivors. The greatest risks of this study include frustration, worsening of emotional distress, data breach, and/or loss of confidentiality. Alternative treatments include contacting your primary care provider or your oncology care team to discuss other available treatments for depressed mood.
CONDITIONS
Official Title
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age greater than 18 years
- Living with likely incurable cancer as determined during manual chart review
- Elevated depressive symptoms with a PHQ-9 score of 8 or higher
- Current owner of an iOS- or Android-compatible smartphone
- Willingness to use a mobile app for depression treatment
- Have a valid email address checked regularly or regular access to text messages
- Fluent in English
You will not qualify if you...
- Current suicidal thoughts as indicated by item nine of the PHQ-9
- Severe cognitive impairment preventing informed consent, including prior diagnosis of dementia or major neurocognitive disorder
- Self-reported cognitive difficulties that impair functional independence
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medical University of South Carolina
Charleston, South Carolina, United States, 29425
Actively Recruiting
Research Team
J
Jennifer Dahne, Ph.D.
CONTACT
N
Noelle Natale
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here